Product Details

Wyost (Preservative Free)

Denosumab
120 mg/1.7 mL
Solution for Subcutaneous Injection
Single-Use Vial Pack

DIN/PIN/NPN

02545764

Manufacturer

Sandoz Canada Inc.

Formulary Listing Date

2024-08-30  

Unit Price

312.0000

Amount MOH Pays

312.0000

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

M05BX04

Interchangeable Products

NO  

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
686 1 year

For the treatment of bony metastases for patients with hormone refractory prostate cancer as determined by an elevated PSA level, or evidence of progressive bony disease, despite castrate serum testosterone levels (less than 1.7nmol/L or less than 50ng/dL) or having undergone orchidectomy.

Dose: 120mg SC every 4 weeks

 

EAP Criteria

NO

Product Monograph

View Monograph